| Vigabatrin.: An article from: Pediatric Nursing | Digitalby Jenny Calli (Author), Elizabeth Farrington (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Jannetti Publications, Inc. | | Page Count: | 18 Pages | | Publication Date: | July 01, 1998 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Pediatric Nursing, published by Jannetti Publications, Inc. on July 1, 1998. The length of the article is 5164 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the supplier: Vigabatrin, a drug used to treat epilepsy in children, is a synthetic drug. It was designed to increase the neurotransmitter y-amino-butyric acid. The drug exhibits a favorable profile and has a few drug interactions because of its lack of protein binding. The assessment of adverse effects with antiepileptic drugs is difficult because effects can be due to epilepsy itself.Citation DetailsTitle: Vigabatrin.Author: Jenny CalliPublication: Pediatric Nursing (Refereed)Date: July 1, 1998Publisher: Jannetti Publications, Inc.Volume: v24 Issue: n4 Page: p357(5)Distributed by Thomson Gale |
|
